FAKTOR OPTIONSSCHEIN - BIOGEN IDEC | Real-time BOERSE MUENCHEN 12:45:12 20/05/2024 BST | ||
| 8.22 EUR | -0.60% |
|
| Current month | -27.07% | ||
| 1 month | -53.54% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
| Date | Price | Change |
|---|---|---|
| 20/05/24 | 8.22 | -0.60% |
| 17/05/24 | 8.27 | +0.24% |
| 16/05/24 | 8.25 | +7.84% |
| 15/05/24 | 7.65 | -16.48% |
| 14/05/24 | 9.16 | -1.61% |
Real-time BOERSE MUENCHEN
Last update May 20, 2024 at 12:45 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HD36C3 |
| ISIN | DE000HD36C38 |
| Date issued | 28/02/2024 |
| Strike | 288.3 $ |
| Maturity | Unlimited |
| Parity | 6.92 : 1 |
| Emission price | 10.77 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 18.91 € |
|---|---|
| Lowest since issue | 7.52 € |
| Spread | 0.1 € |
| Spread % | 1.22% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
230.6
USD
Average target price
285.9
USD
Spread / Average Target
+24.01%
- Stock Market
- Certificates
- Certificat
